Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionOstrum Asset Management
Latest Disclosed Ownership22,289 shares
Latest Disclosed Value $ 2,288,412
Ostrum Asset Management reports 11.77% decrease in ownership of ABL / Abbott Laboratories

On May 14, 2026 - Ostrum Asset Management filed a 13F-HR form disclosing ownership of 22,289 shares of Abbott Laboratories (DE:ABL) valued at $1,979,709 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 25,262 shares of Abbott Laboratories. This represents a change in shares of -11.77% during the quarter. The current value of the position is $1,676,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBOTT LABORATORIES Common Stock 002824100 22,289 -2,973 -11.77 2,288 -27.71 0.1285
2026-02-13 2025-12-31 13F ABBOTT LABS Common Stock 002824100 25,262 -2,913 -10.34 3,165 -16.11 0.1518
2025-11-14 2025-09-30 13F ABBOTT LABS Common Stock 002824100 28,175 7,604 36.96 3,774 34.89 0.1695
2025-08-13 2025-06-30 13F ABBOTT LABS Common Stock 002824100 20,571 -1,843 -8.22 2,798 -5.92 0.1311
2025-05-14 2025-03-31 13F ABBOTT LABS Common Stock 002824100 22,414 5,159 29.90 2,973 52.38 0.1565
2025-02-13 2024-12-31 13F ABBOTT LABS Common Stock 002824100 17,255 -5,759 -25.02 1,952 -25.62 0.1690
2024-11-13 2024-09-30 13F ABBOTT LABS Common Stock 002824100 23,014 459 2.04 2,624 11.95 0.2171
2024-08-13 2024-06-30 13F ABBOTT LABS Common Stock 002824100 22,555 -3,163 -12.30 2,344 -19.84 0.2044
2024-05-13 2024-03-31 13F ABBOTT LABS Common Stock 002824100 25,718 90 0.35 2,923 3.65 0.2310
2024-02-13 2023-12-31 13F ABBOTT LABS Common Stock 002824100 25,628 3,801 17.41 2,821 33.46 0.2452
2023-11-14 2023-09-30 13F ABBOTT LABS Common Stock 002824100 21,827 -2,641 -10.79 2,114 -20.77 0.1956
2023-08-11 2023-06-30 13F ABBOTT LABS Common Stock 002824100 24,468 43 0.18 2,668 7.84 0.2236
2023-05-12 2023-03-31 13F ABBOTT LABS Common Stock 002824100 24,425 24,425 2,473 0.2155
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.